MUC1 expression by immunohistochemistry is associated with adverse pathologic features in prostate cancer: A multi-institutional study
Okyaz Eminaga, Wei Wei, Sarah J. Hawley, Heidi Auman, Lisa F. Newcomb, Jeff Simko, Antonio Hurtado-Coll, Dean A. Troyer, Peter R. Carroll, Martin E. Gleave, Daniel W. Lin, Peter S. Nelson, Ian M. Thompson, Lawrence D. True, Jesse K. McKenney, Ziding Feng, Ladan Fazli, James D. Brooks
Profundice en los temas de investigación de 'MUC1 expression by immunohistochemistry is associated with adverse pathologic features in prostate cancer: A multi-institutional study'. En conjunto forman una huella única.